683 Capital Management, LLC Syndax Pharmaceuticals Inc Transaction History

683 Capital Management, LLC

$1.1 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$19.35 - $22.31 $6.39 Million - $7.36 Million	-330,000 Reduced 84.62%	60,000 $1.26 Million
Q1 2023 May 15, 2023	SELL	$20.66 - $28.98 $3.72 Million - $5.22 Million	-180,000 Reduced 31.58%	390,000 $8.24 Million
Q4 2022 Feb 14, 2023	SELL	$20.64 - $26.24 $11.6 Million - $14.7 Million	-560,000 Reduced 49.56%	570,000 $14.5 Million
Q3 2022 Nov 14, 2022	SELL	$18.51 - $24.79 $8.36 Million - $11.2 Million	-451,653 Reduced 28.56%	1,130,000 $27.2 Million
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $2.76 Million - $4.12 Million	186,161 Added 13.34%	1,581,653 $27.5 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $3.95 Million - $5.83 Million	259,592 Added 22.85%	1,395,492 $30.5 Million
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $693,500 - $990,000	50,000 Added 4.6%	1,135,900 $21.7 Million
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $3.37 Million - $6.32 Million	250,900 Added 30.05%	1,085,900 $18.6 Million
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $2.96 Million - $3.77 Million	-153,406 Reduced 15.52%	835,000 $18.7 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $2.42 Million - $4.23 Million	160,035 Added 19.32%	988,406 $22 Million
Q3 2020 Nov 16, 2020	SELL	$13.39 - $17.48 $2.52 Million - $3.29 Million	-188,000 Reduced 18.5%	828,371 $12.2 Million
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $744,997 - $1.75 Million	83,333 Added 8.93%	1,016,371 $15.1 Million
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $53,452 - $96,697	8,038 Added 0.87%	933,038 $10.2 Million
Q4 2019 Feb 14, 2020	SELL	$5.43 - $9.22 $1.34 Million - $2.27 Million	-246,648 Reduced 21.05%	925,000 $8.12 Million
Q3 2019 Nov 14, 2019	SELL	$7.47 - $10.76 $3.32 Million - $4.78 Million	-444,307 Reduced 27.5%	1,171,648 $8.75 Million
Q2 2019 Aug 14, 2019	BUY	$4.9 - $9.31 $86,230 - $163,837	17,598 Added 1.1%	1,615,955 $15 Million
Q1 2019 May 15, 2019	BUY	$4.26 - $6.86 $1.09 Million - $1.75 Million	255,518 Added 19.03%	1,598,357 $8.39 Million
Q4 2018 Feb 14, 2019	BUY	$3.6 - $8.42 $2.96 Million - $6.92 Million	821,839 Added 157.74%	1,342,839 $5.98 Million
Q3 2018 Nov 14, 2018	BUY	$6.33 - $8.08 $924,180 - $1.18 Million	146,000 Added 38.93%	521,000 $4.21 Million
Q2 2018 Aug 14, 2018	BUY	$6.93 - $14.63 $635,966 - $1.34 Million	91,770 Added 32.4%	375,000 $2.63 Million
Q1 2018 May 15, 2018	BUY	$8.71 - $14.82 $2.47 Million - $4.2 Million	283,230 New	283,230 $4.03 Million

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

Black Rock Inc. New York, NY

7.91M
Shares

$127 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

5.84M
Shares

$94 Million
9.23% of portfolio
Wellington Management Group LLP Boston, MA

4.99M
Shares

$80.2 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$78.6 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

4.11M
Shares

$66.1 Million
6.25% of portfolio

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $910M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Account